Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study

Completed · Phase 2/Phase 3

Conditions studied: Malaria, Lymphatic Filariasis

In brief

The purpose of this study is to determine whether repeated ivermectin mass drug administrations to Burkinabé villagers, performed in three week intervals over the rainy-season, is well-tolerated and safe, and also effective in reducing local malaria transmission and thus clinical malaria episodes in treated village children.

Key facts

Study ID

NCT02509481

Run by

Colorado State University

People needed

2712

Starts

2015-06-01

Expected to finish

2015-12-01

Last updated by the study team

2019-01-04

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Residence in the study site
• Able to understand the information and willing to give consent and assent (parent or guardian consent if study participant age is < 18 years)

You may not qualify if…

• Residence outside of in the study site
• Height ≤ 90 cm
• Permanent disability, serious medical illness that prevents or impedes study participation and/or comprehension
• Pregnancy
• Breast feeding if infant is within 1 week of birth
• Known allergy to the study drugs

Where it is running

• Colorado State University — Fort Collins, Colorado, United States
• Institut de Recherche en Sciences de la Santé — Bobo-Dioulasso, Houet, Burkina Faso

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.